[fcb5af]: / literature / by_gene / BTG1.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 34657128 10.1038/s41375-021-01448-2 2022 Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study. BTG1
2 34791836 10.1002/cam4.4422 2022 Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial. BTG1
3 35401516 10.3389/fimmu.2022.842439 2022 Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma. BTG1
4 35459639 10.1016/j.bpj.2022.04.023 2022 Conformational transitions in BTG1 antiproliferative protein and their modulation by disease mutants. BTG1
5 35646048 10.3389/fgene.2022.878618 2022 Whole-Genome/Exome Sequencing Uncovers Mutations and Copy Number Variations in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System. BTG1
6 35774514 10.3389/fgene.2022.827840 2022 A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma. BTG1
7 35795062 10.3389/fonc.2022.870487 2022 Plasma Concentrations and Cancer-Associated Mutations in Cell-Free Circulating DNA of Treatment-Naive Follicular Lymphoma for Improved Non-Invasive Diagnosis and Prognosis. BTG1
8 35880434 2022 Emerging role of anti-proliferative protein BTG1 and BTG2. BTG1
9 32467145 10.3324/haematol.2020.247973 2021 Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913. BTG1
10 33021411 10.1080/10428194.2020.1827243 2021 Frequent loss of BTG1 activity and impaired interactions with the Caf1 subunit of the Ccr4-Not deadenylase in non-Hodgkin lymphoma. BTG1
11 33777778 10.3389/fonc.2021.628807 2021 Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma. BTG1
12 34010787 10.1016/j.ejca.2021.03.034 2021 Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials. BTG1
13 34371436 10.1016/j.leukres.2021.106683 2021 Proposal and clinical application of molecular genetic risk scoring system, MRplus, for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre. BTG1
14 34599153 10.1038/s41419-021-04187-5 2021 Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma. BTG1
15 35116576 10.21037/tcr-20-2525 2021 Identification of key mutations in central nervous diffuse large B-cell lymphoma (DLBCL) by comprehensive analysis between sequencing and TCGA database. BTG1
16 32592278 10.1002/gcc.22882 2020 Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol. BTG1
17 32661308 10.1038/s41598-020-68311-9 2020 MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia. BTG1
18 33252851 10.1002/ctm2.221 2020 Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma. BTG1
19 33369444 10.31557/APJCP.2020.21.12.3493 2020 Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis. BTG1
20 30350856 10.1002/jcp.27407 2019 Tumor suppressors BTG1 and BTG2: Beyond growth control. BTG1
21 30854058 10.3892/ol.2019.9900 2019 Identification of B-cell translocation gene 1-controlled gene networks in diffuse large B-cell lymphoma: A study based on bioinformatics analysis. BTG1
22 30874617 10.1038/s41598-019-41078-4 2019 Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia. BTG1
23 31112375 10.1111/ijlh.13052 2019 Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay. BTG1
24 31228652 10.1016/j.leukres.2019.05.009 2019 Prognostic gene alterations and clonal changes in childhood B-ALL. BTG1
25 29348129 10.1182/blood-2017-07-796862 2018 Genomic CDKN2A/2B deletions in adult Ph<sup>+</sup> ALL are adverse despite allogeneic stem cell transplantation. BTG1
26 29407587 10.1016/j.leukres.2018.01.012 2018 High frequency of intermediate and poor risk copy number abnormalities in pediatric cohort of B-ALL correlate with high MRD post induction. BTG1
27 29498923 10.1200/JCO.2017.74.3617 2018 IKZF1<sup>plus</sup> Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. BTG1
28 29786757 10.1007/s12185-018-2474-7 2018 Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes. BTG1
29 30203896 10.1002/gcc.22664 2018 Improved cytogenetic characterization and risk stratification of pediatric acute lymphoblastic leukemia using single nucleotide polymorphism array analysis: A single center experience of 296 cases. BTG1
30 27339065 10.1080/10428194.2016.1193855 2017 Gene copy number alteration profile and its clinical correlation in B-cell acute lymphoblastic leukemia. BTG1
31 27979924 10.3324/haematol.2016.153023 2017 Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients. BTG1
32 28033648 10.1002/gcc.22439 2017 Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia. BTG1
33 28202519 10.1158/0008-5472.CAN-16-2571 2017 Correlates of Prenatal and Early-Life Tobacco Smoke Exposure and Frequency of Common Gene Deletions in Childhood Acute Lymphoblastic Leukemia. BTG1
34 28401483 10.1007/s12032-017-0940-3 2017 Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients. BTG1
35 28886309 10.14715/cmb/2017.63.8.4 2017 The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia. BTG1
36 28947432 10.1158/1940-6207.CAPR-17-0121 2017 <i>IKZF1</i> Gene in Childhood B-cell Precursor Acute Lymphoblastic Leukemia: Interplay between Genetic Susceptibility and Somatic Abnormalities. BTG1
37 26657730 10.18632/oncotarget.6519 2016 Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress. BTG1
38 26781410 2016 [Detection of copy number variations in pediatric ETV6/RUNX1-positive acute lymphoblastic leukemia with multiplex ligation-dependent probe amplification]. BTG1
39 26957068 10.3760/cma.j.issn.0578-1310.2016.03.011 2016 [Copy number variations in pediatric ETV6/RUNX1 positive acute lymphoblastic leukemia]. BTG1
40 27036158 10.3324/haematol.2015.139675 2016 Tumor suppressors BTG1 and BTG2 regulate early mouse B-cell development. BTG1
41 27151989 10.3324/haematol.2016.143875 2016 Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia. BTG1
42 27229005 10.1182/blood-2016-03-704973 2016 Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia. BTG1
43 27959929 10.1371/journal.pmed.1002197 2016 Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study. BTG1
44 25571854 10.3892/ijmm.2014.2058 2015 B cell translocation gene 1 reduces the biological outcome of kidney cancer through induction of cell proliferation, cell cycle arrest, cell apoptosis and cell metastasis. BTG1
45 25710169 10.1371/journal.ppat.1004652 2015 HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma-associated herpesvirus ORF57 protein and host pre-mRNA metabolism. BTG1
46 25951811 10.1002/gcc.22251 2015 Identification of SPAG9 as a novel JAK2 fusion partner gene in pediatric acute lymphoblastic leukemia with t(9;17)(p24;q21). BTG1
47 24366360 10.1182/blood-2013-09-525808 2014 The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. BTG1
48 24957142 10.1182/blood-2014-03-562918 2014 A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia. BTG1
49 24998463 10.1016/j.cancergen.2014.05.003 2014 High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia. BTG1
50 25044358 10.1002/gcc.22201 2014 Gene alterations involving the CRLF2-JAK pathway and recurrent gene deletions in Down syndrome-associated acute lymphoblastic leukemia in Japan. BTG1
51 25117713 10.1016/j.ccr.2014.06.014 2014 MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state. BTG1
52 25173640 10.1007/s13277-014-2298-x 2014 Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis. BTG1
53 22868968 10.1038/leu.2012.199 2013 BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia. BTG1
54 22072402 10.1002/gcc.20944 2012 High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome. BTG1
55 22343534 10.1073/pnas.1121343109 2012 Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. BTG1
56 22359517 10.1371/journal.pgen.1002533 2012 The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution. BTG1
57 22851563 10.1200/JCO.2011.40.3907 2012 IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia. BTG1
58 20354172 10.1182/blood-2009-05-223081 2010 BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia. BTG1
59 17374122 10.1111/j.1349-7006.2007.00443.x 2007 Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization. BTG1
60 17466295 10.1016/j.yexcr.2007.03.021 2007 Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement. BTG1
61 17485552 10.1182/blood-2006-12-064865 2007 Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors. BTG1
62 11920564 10.1002/1521-4141(200204)32:4&lt;982::AID-IMMU982&gt;3.0.CO;2-I 2002 Expression profiling in transformed human B cells: influence of Btk mutations and comparison to B cell lymphomas using filter and oligonucleotide arrays. BTG1